Buys
Open market- Shares
- Avg price
- Total value
Freddy A. Jimenez - SVP & GENERAL COUNSEL at Celldex Therapeutics, Inc.
Issuer-level insider activity
- Role
- Svp & General Counsel
- Issuer ticker
- CLDX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Freddy A. Jimenez in Celldex Therapeutics, Inc.
Sells
Open market- Shares
- -4,166
- Avg price
- $29.10
- Total value
- -$121,210
Net
Past year- Shares
- -4,166
- Share %
- -100%
- Total value
- -$121,210
Reported holdings for Freddy A. Jimenez in Celldex Therapeutics, Inc.
Form 4 holding
SVP & GENERAL COUNSEL
Celldex Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 30,796
- Estimated value
- $896,009
- Report date
- 04 Dec 2025
- Price
- $29.10
- Ownership
- Direct
Form 4 holding
SVP & GENERAL COUNSEL
Celldex Therapeutics, Inc.
- Security class
- Incentive Stock Option (right to buy)
- Shares / value
- 93,000
- Estimated value
- Report date
- 25 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Freddy A. Jimenez in Celldex Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.